+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Thrombocytosis"

Global Non-Cancerous Blood Disease Market Analysis 2021-2031 - Product Thumbnail Image

Global Non-Cancerous Blood Disease Market Analysis 2021-2031

  • Report
  • April 2022
  • 307 Pages
  • Global
From
Neonatal Haematology. A Practical Guide. Edition No. 1 - Product Thumbnail Image

Neonatal Haematology. A Practical Guide. Edition No. 1

  • Book
  • September 2022
  • 304 Pages
Platelets. Edition No. 4 - Product Thumbnail Image

Platelets. Edition No. 4

  • Book
  • May 2019
  • 7 Results (Page 1 of 1)
Loading Indicator

Thrombocytosis is a hematological disorder characterized by an abnormally high platelet count in the blood. Platelets are small cell fragments that help the blood to clot. Thrombocytosis can be caused by a variety of conditions, including certain types of cancer, anemia, and inflammatory diseases. It can also be caused by certain medications, such as chemotherapy drugs. Symptoms of thrombocytosis include fatigue, dizziness, and shortness of breath. Treatment for thrombocytosis typically involves medications to reduce the platelet count, as well as lifestyle changes to reduce the risk of complications. There are several companies that specialize in the treatment of thrombocytosis. These include Novartis, Pfizer, and Bristol-Myers Squibb. Other companies that offer products and services related to thrombocytosis include Roche, Amgen, and Merck. Show Less Read more